VGX-3100 III期临床再获突破，宫颈癌前病变首个DNA疗法还会远吗？
两次III期临床的成功，将在多大程度改变宫颈癌前病变的治疗？
Time：
2023-03-05 10:05
Author：
写意君
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务